Logo
Secure Registration

International Conference on Biomedical Engineering in Cancer Research

21st Sep – 22nd Sep 2026 Ankara, Turkey

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

!
Standard Registration Closed
The deadline for Standard Participation has ended. Participants may continue with Virtual Registration to join the conference remotely.
2

Participant Details

3

Coupon Code

4

Terms & Condition

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 9
01 Advancements in Predictive Modeling for Cancer Treatment +

This track focuses on the latest methodologies in predictive modeling specifically tailored for cancer treatment. It aims to explore how these models can enhance decision-making processes in clinical settings.

02 Machine Learning Techniques in Tumor Analysis +

This session will delve into the application of supervised and unsupervised learning techniques in the analysis of tumor data. Participants will discuss the effectiveness of these approaches in improving diagnostic accuracy.

03 Deep Learning Applications in Cancer Research +

This track highlights the transformative impact of deep learning technologies in various aspects of cancer research. It will cover case studies demonstrating their utility in image analysis, genomics, and treatment personalization.

04 Anomaly Detection in Biomedical Data +

This session will explore innovative approaches to anomaly detection within biomedical datasets related to cancer. Emphasis will be placed on identifying outliers that could signify critical insights into disease progression.

05 Feature Extraction Techniques in Cancer Biomarker Discovery +

This track will investigate advanced feature extraction techniques used in the discovery of cancer biomarkers. Discussions will focus on how these techniques can lead to more effective diagnostic and therapeutic strategies.

06 Workflow Automation in Biomedical Engineering +

This session will address the role of workflow automation in enhancing efficiency within biomedical engineering processes. Participants will share insights on integrating automation into research and clinical workflows.

07 System Monitoring and Predictive Maintenance in Healthcare +

This track will focus on the implementation of system monitoring and predictive maintenance strategies in healthcare settings. The discussions will highlight how these practices can improve operational efficiency and patient outcomes.

08 Digital Twin Technologies in Cancer Research +

This session will examine the emerging concept of digital twins in the context of cancer research. Participants will discuss how digital twin technologies can simulate tumor behavior and inform therapeutic design.

09 Process Optimization in Cancer Treatment Protocols +

This track will explore methodologies for process optimization in cancer treatment protocols. The focus will be on how engineering principles can streamline treatment delivery and improve patient care.

10 Simulation and Analytics in Cancer Research +

This session will highlight the use of simulation and analytics tools in cancer research. Participants will discuss their applications in modeling disease progression and evaluating treatment efficacy.

11 Molecular Modeling and Therapeutic Design in Oncology +

This track will focus on the integration of molecular modeling techniques in the design of novel therapeutics for cancer. Discussions will center on how these approaches can lead to more targeted and effective treatment options.